EORTC-1301 (FL)

EORTC-1301 (FL)

10-day Decitabine Versus Conventional Chemotherapy ("3+7") Followed by Allografting in AML Patients ≥ 60 Years: a Randomized Phase III Study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study (EORTC1301) 


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link